The objective of this experiment was to determine if supplementing propionate alters DMI, glucose clearance rate, and blood metabolite concentrations in steers fed a finishing diet. Holstein (n = 15) steers were individually fed a finishing diet ad-libitum. Steers were allocated by BW to receive: no Ca propionate (CON), 100 g/d (LOW), or 300 g/d (HIGH) in the diet. Orts were collected and weighed daily to determine DMI. Blood samples were collected on d 0, 7, and 21, and BW recorded on d 0, 14, and 28. A glucose tolerance test was conducted on d 14 and 28 of the trial. Samples were analyzed for whole blood glucose and lactate, and plasma NEFA. Data were analyzed using a mixed model with treatment, day and their interaction included, with day as a repeated measure. The CON treatment had greater (P < 0.01) DMI than LOW and HIGH. BW was greater for CON throughout the experiment and all treatments had an increased BW on day 28 (P = 0.03 for the interaction). Whole blood glucose concentrations tended (P = 0.09) to be higher on d 21 than d 0 and 7, but was not affected by treatment (P = 0.58). Plasma NEFA concentrations were lower (P = 0.05) for CON than other treatments, and greater (P = 0.002) on d 0 than d 7 and 21. Whole blood lactate concentrations were greater (P = 0.05) on d 7, than d 0 and 21, but was not effected by treatment (P = 0.13). There was no treatment (P ≥ 0.16) or day effect (P ≥ 0.36) on glucose peak, plateau, or clearance rate. These data indicate that supplemental propionate may decrease dry matter intake but might not alter glucose clearance rate.
The objective of this experiment was to determine the effects of dietary vitamin D source on serum calcium (Ca), urinary Ca excretion and milk production when fed in combination with a prepartum acidogenic negative DCAD diet. Non-lactating, pregnant multiparous cows (n=15), balanced for breed (Holstein n = 9 and Jersey n = 6) and previous mature equivalent milk production, were assigned to 1 of 3 treatments (5 cows/treatment), consisting of a control (PCH; positive DCAD, 8.9 mEq/100g DM) and two negative DCAD diets (-15.4 mEq/100g DM), one with vitamin D3 (Cholecalciferol; NCH), and one with 25-hydroxyvitamin D3 (calcidiol; NCA; DSM Nutritional Products). The treatments were formulated to provide 1.95 mg/d of vitamin D and were fed 28 d prior to expected calving date. Delivery of vitamin D sources was accomplished by manufacture of a pellet and 2 kg of these pellets were individually fed simultaneously each day along with 2 kg of ground corn daily at 0800. Negative DCAD treatments were formulated to provide 0.46 kg/d of Animate (Phibro Animal Health) and, if needed, additional Animate was top-dressed at each feeding to achieve a urine pH between 5.5 – 6.0 based on the previous day’s urine pH. Close-up cows had ad libitum access to chopped bermudagrass (Cynodon dactylon L.) hay and hay intake was measured using SmartFeed Pro systems (C-Lock Inc.; Rapid City, SD). Prepartum urine and serum samples were collected weekly and serum was collected 36, 48, and 72 h post-calving. Prepartum DMI as a percent of body weight was not (P = 0.66) affected by treatments. Cows fed NCH and NCA had greater (P = 0.02) prepartum serum Ca than PCH and tended to have greater urinary Ca excretions (P = 0.10). Average postpartum serum Ca (mg/dL) was greater (P = 0.05) for cows fed NCH (8.8) compared with PCH (7.8), whereas NCA (8.4) was numerically intermediate and not (P > 0.05) different from either of the other treatments. Postpartum DMI was not affected by treatment (P = 0.39). Daily MY (kg/d) was greatest (P < 0.01) for NCA (37.5) compared with the other treatments and NCH (34.1) was intermediate and greater than PCH (29.9). These results suggest that an acidogenic prepartum diet in combination with vitamin D was effective in maintaining peripartum serum Ca and the 25-hydroxy form of vitamin D improved MY compared with NCH in early lactation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.